Number of cancer innovative drug clinical trials in China 2016-2020
In 2020, despite the COVID-19 pandemic, almost 600 innovative cancer drug clinical trials were conducted in China, representing a sharp increase of more than 200 trials from 2019. In comparison, only less than 200 trials of innovative cancer drugs were conducted in 2016. The rise in figures reflects the fast development of the innovative drug industry in China.